BRAINSTORM CELL THERAPEUTICS INC. - COM NEW (BCLI)

Historical Portfolio Holders from Q3 2014 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q2 2024
12.1M
Holdings value Q2 2024
$4.08M
Value change Q2 2024
+$2.71M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
44
Number of buys Q2 2024
17
Number of sells Q2 2024
-15
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 12.1M $4.08M +$2.71M $0.34 46
2024 Q1 3.88M $2.19M +$83.3K $0.56 45
2023 Q4 3.8M $1.04M -$159K $0.27 46
2023 Q3 4.63M $928K -$3.14M $0.20 54
2023 Q2 5.57M $11.5M -$1.69M $2.06 57
2023 Q1 6.18M $20.4M +$8.17M $3.30 46
2022 Q4 3.67M $6.02M -$247K $1.64 42
2022 Q3 3.87M $17.1M +$95.5K $4.42 39
2022 Q2 3.95M $10.9M -$598K $2.76 41
2022 Q1 4.14M $15.2M -$1.12M $3.36 36
2021 Q4 4.4M $17.6M -$2.48M $4.00 41
2021 Q3 5.13M $16.9M -$1.75M $3.30 50
2021 Q2 5.63M $21.4M -$10.5M $3.80 54
2021 Q1 8.4M $32.1M -$25.8K $3.83 71
2020 Q4 8.19M $37.1M -$1.05M $4.53 85
2020 Q3 6.8M $115M +$11.5M $16.92 81
2020 Q2 6.24M $70M +$28.8M $11.21 76
2020 Q1 3.69M $17.1M +$7.57M $4.64 51
2019 Q4 2.07M $8.85M -$185K $4.28 41
2019 Q3 2.11M $8.24M +$705K $3.90 38
2019 Q2 1.93M $7.61M -$1.94M $3.95 35
2019 Q1 2.41M $10.5M -$161K $4.34 37
2018 Q4 2.45M $8.69M +$245K $3.55 33
2018 Q3 2.37M $9.04M -$256K $3.82 33
2018 Q2 2.43M $9.48M +$3.27M $3.90 35
2018 Q1 1.68M $5.28M -$550K $3.15 32
2017 Q4 1.82M $7.11M +$707K $3.91 34
2017 Q3 1.63M $6.71M -$2.46M $4.12 32
2017 Q2 2.39M $9.23M +$4.96M $4.15 26
2017 Q1 1.03M $4.36M -$846K $4.24 25
2016 Q4 1.55M $3.94M +$636K $2.54 26
2016 Q3 1.31M $3.14M -$767K $2.40 23
2016 Q2 1.63M $3.93M -$179K $2.41 21
2016 Q1 1.7M $4.52M +$520K $2.67 27
2015 Q4 1.49M $4.25M -$992K $2.86 21
2015 Q3 1.92M $4.39M +$245K $2.29 20
2015 Q2 1.79M $6.48M -$2.29M $3.62 19
2015 Q1 2.41M $10.7M +$10.3M $4.45 20
2014 Q4 103K $488K -$3.29M $4.76 10
2014 Q3 917K $3.78M +$3.78M $4.18 7